XASX
TYR
Market cap306mUSD
Jul 10, Last price
0.83AUD
1D
1.84%
1Q
5.73%
IPO
-75.22%
Name
Tyro Payments Ltd
Chart & Performance
P/E
24.74
P/S
0.93
EPS
0.03
Div Yield, %
—
Shrs. gr., 5y
2.51%
Rev. gr., 5y
17.29%
Revenues
473m
-4.98%
Net income
18m
-30.69%
CFO
138m
+183.10%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Tyro Payments Limited, an Australian company founded in Sydney in 2003, delivers a comprehensive array of payment and banking services to businesses nationwide. The firm operates through distinct Payments and Banking divisions. Its offerings include electronic funds transfer at point of sale (EFTPOS) terminals and the processing of credit, debit, and EFTPOS card transactions. Tyro also provides specialized services for Medicare and private health fund claiming and rebates. Innovative solutions comprise Tyro Go, a mobile card reader for on-the-go payments, and Tyro Connect, an integration platform designed to link various applications and services with point-of-sale systems, especially useful for establishments like cafes, restaurants, and bars. Additionally, Tyro developed Medipass, a digital health payment platform that streamlines interactions among healthcare practitioners, payers, and patients. On the banking front, the company offers business loans and supplementary financial products such as merchant cash advances, transaction accounts, and term deposit accounts. Tyro's client base encompasses a broad range of sectors, including healthcare, hospitality, services, corporate, accommodation, and retail.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||